Funded Tech Companies
Sudo Biosciences
Operating out of Menlo Park, Sudo Biosciences raised its funding from Leaps by Bayer, UPMC Enterprises and Dementia Discovery Fund.
Company Overview
Company Name
Sudo Biosciences
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
Undisclosed
Menlo Park, CA Undisclosed
USA
Menlo Park, CA Undisclosed
USA
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Sudo Biosciences is a biopharmaceutical company committed to designing and developing novel, best-in-class medicines to transform patients' lives. Our lead programs target the tyrosine kinase 2 (TYK2) pseudokinase domain. TYK2 is a key mediator in cytokine signaling pathways that have been linked to a broad range of immune-mediated inflammatory conditions.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
2/13/2024
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Scott Byrd
Company Investors
- Leaps by Bayer
- UPMC Enterprises
- Dementia Discovery Fund
- Enavate Sciences
- Sanofi Ventures
- Frazier Life Sciences
- Monograph Capital
- TPG Rise Climate Fund
- Velosity Capital
- Eventide Asset Management
- Surveyor Capital
- Frazier Healthcare Partners (Dan Estes)
Browse more funded tech companies:
Sudden Coffee | Sudo Technologies
Share this article
About Our VC Deals Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs